Delivery Order SPE2DB20D3101-SPE2DB23FRMF7
Award Date 5/23/23
Potential Completion Date 5/24/23
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,023.63 firm fixed-price delivery order is for the supply of 100 capsules of the medication Lotrel 5-10 mg. The contract has an ultimate completion date of July 14, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $69,407.95, is for the delivery of 4,556,966,047 units of the prescription medication Lotrel 10-20 mg capsules. This is a Firm Fixed Price delivery order contract, with an ultimate completion date of April 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award, valued at $33,506.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of 4,556,447,587 units of the cardiovascular medication Lotrel 10-20 mg capsules in 100-count bottles. This is a firm-fixed-price delivery order contract, with a completion date of March 4, 2022. The contract was awarded on an unrestricted, full and open competition basis, with no set-aside...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp for $1,398.98 on February 3, 2026, for the supply of Lotrel 5-10 mg capsules (100-count units). This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031. The delivery order is scheduled for ultimate completion on...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,130.61 Firm Fixed Price Delivery Order contract is for the supply of LOTREL 5-20 MG CAPSULE 100S, a cardiovascular medication. The contract has a completion date of February 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,749.29 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LOTREL 10-20 MG CAPSULE 100S. The $3,678.83 firm-fixed-price delivery order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a...
- This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,311.27 delivery order is for the supply of Lotrel 10-20 mg capsules, a medication used to treat high blood pressure. The contract has an ultimate completion date of October 25, 2023 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LOTREL 10-20 mg capsules. The award, with a ceiling value of $10,628.38, has a period of performance through September 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, to provide a wide range of medical commodities, including...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,090.96 firm fixed-price delivery order is for the supply of Lotrel 10-20 mg capsules. The contract has an ultimate completion date of June 20, 2023 and was awarded on June 16, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...